vTv Therapeutics Profit Margin

vTv Therapeutics (VTVT) currently reports a profit margin of -20.86% as of September 2026. That compares with -138058.82% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore vTv Therapeutics's profit margin history and peer comparisons.

vTv Therapeutics's profit margin increased from -138058.82% to -20.86% — a 100.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

vTv Therapeutics's profit margin of -20.86% is lower than the Healthcare sector average of 19.13%. That is roughly 209.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but vTv Therapeutics's current -20.86% should be judged against Healthcare norms (sector average: 19.13%) and against VTVT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -20.86%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for vTv Therapeutics, and consider following VTVT for alerts when major investors trade the stock.